To Assess the Effectiveness and Safety of Zepzelca in Adult Patients With Extensive Stage Small Cell Lung Cancer (SCLC)

NCT04894591 · clinicaltrials.gov ↗

COMPLETED

Status

272

Enrollment

INDUSTRY

Sponsor class

Conditions

Extensive-stage Small-cell Lung Cancer

Interventions

DRUG: Zepzelca

Sponsor

Jazz Pharmaceuticals